| Financial Year |
March 31 2023 |
| Monetary Funds |
1,568,035,691.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,520,215.91 |
| Accounts Receivable |
863,003,439.28 |
| Advances to Suppliers |
76,739,857.39 |
| Other Receivables |
339,958,890.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,423,153,212.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,017,485.38 |
| Other Current Assets |
11,567,035.79 |
| Total Current Assets |
4,814,855,828.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
615,600.00 |
| Long-term Equity Investment |
114,150,885.07 |
| Investment Properties |
23,387,803.33 |
| Fixed Assetes |
527,235,414.77 |
| Under-construction Projects |
13,820,530.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,952,319.77 |
| R&D expenses |
-- |
| Goodwill |
384,246,409.24 |
| Long-Term Deferred and Prepaid Expenses |
26,462,672.54 |
| Deferred Income Tax Assets |
18,773,343.36 |
| Other Non-Current Assets |
5,870,236.09 |
| Sub-Total of Non-Current Assets |
1,343,481,363.28 |
| Total Assets |
6,158,337,192.06 |
| Short-Term Loans |
1,951,955,119.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,755,915.68 |
| Accounts Payable |
621,630,254.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,605,226.11 |
| Taxes Payable |
44,432,077.77 |
| Interest Payable |
-- |
| Dividend Payable |
710,700.00 |
| Other payables |
108,870,218.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
766,499,410.08 |
| Other Current Liabilities |
8,214,067.51 |
| Sub-Total of Current Liabilities |
4,006,723,840.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,598,131.69 |
| Deferred Income Tax Liabilities |
5,968,777.54 |
| Other Non-Current Liabilities |
34,663,716.80 |
| Sub-Total of Non-Current Liabilities |
125,619,042.51 |
| Total Liabilities |
4,132,342,883.01 |
| Paid-In Capital(Or Share Stock) |
663,506,691.00 |
| Capital Surplus |
1,486,336,845.36 |
| Surplus Reserve |
86,873,388.19 |
| LESS:Treasury Stock |
9,195,050.00 |
| Undistributed Profits |
-203,246,384.57 |
| Minority Stockholder's Interest |
-694,089.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,026,688,398.98 |
| Owner's Equity（Stockholder's Equity） |
2,025,994,309.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,158,337,192.06 |
